{
    "nct_id": "NCT03418857",
    "official_title": "The Role of Probiotics in Attenuating Inflammation and Improving Gut Health in Obese Adults",
    "inclusion_criteria": "* BMI ≥ to 25 and less than 35 kg/m^2\n* Increased waist circumference (men: ≥ 94 cm, women: ≥ 80 cm)\n* At least one of the metabolic syndrome criteria-\n* serum triglycerides: ≥ 150 mg/dL\n* HDL cholesterol: ≤ 40 mg/dL in men, ≤ 50 mg/dL in women\n* blood pressure: ≥ 130 mmHg systolic or ≥ 85 mmHg diastolic\n* fasting plasma glucose ≥ 100 mg/dL\nHealthy volunteers allowed\nMust have minimum age of 55 Years\nMust have maximum age of 75 Years",
    "exclusion_criteria": "* allergy to dairy\n* smoking and/or use of tobacco products\n* systolic blood pressure ≥ 160 mmHg\n* diastolic blood pressure > 100 mmHg\n* fasting glucose ≥ 126 mg/dL\n* history of myocardial infarction, cardiovascular disease (CVD), stroke, diabetes mellitus, liver disease, kidney disease, thyroid disease (unless controlled on medication)\n* use of cholesterol or lipid lowering medications\n* use of anti-hypertensive or glucose lowering supplements (psyllium, fish oil capsules, soy lecithin, niacin, fiber, flax, phytoestrogens, and stanol/sterol supplemented foods)\n* refusal to discontinue nutritional supplements, herbs, vitamins, or other probiotics\n* clinical diagnosis of inflammatory bowel disease (IBD) e.g. Chron's disease or ulcerative colitis\n* Use of antibiotics within the last 2 months\n* excessive alcohol consumption (≥ 14 standard drinks per week)\n* regular use of anti-inflammatory medications (e.g. aspirin, ibuprofen)",
    "miscellaneous_criteria": ""
}